In the endplates of rat phrenic nervediaphragm, application of the acetylcholine-like compound, carbachol, causes a marked increase in transmitter release, as measured electrophysiologically using miniature endplate potential frequency. Washing The actions of acetylcholine (ACh) and similar compounds (cholinomimetics) on nerve membranes have been well investigated. ACh causes membrane depolarization of sensory nerve fibers, non-myelinated vagal C-fibers, sympathetic nerve fibers, and preganglionic and motor nerve endings (1-4). At adrenergic nerve terminals, ACh brings about the release of neurotransmitter (2). By contrast, application of cholinomimetics to cholinergic nerve endings has been reported to be ineffective in causing the release of transmitter from available storage sites. Electrophysiological studies at the neuromuscular junction and sympathetic ganglia have failed to detect any increase in the rate of spontaneous release of transmitter packets (miniature potentials*) in response to applied ACh or the cholinomimetic drug, carbachol (3, 4). ACh, in fact, has been shown to cause a decrease in the output of transmitter evoked by motor nerve stimulation (4, 5). Similarly, radiotracer studies at perfused sympathetic ganglia have shown that the application of carbachol apparently does not cause ACh release from transmitter storage sites, even though depolarization of the nerve terminals by K+ and nerve stimulation bring about the release of ACh into the perfusion stream (6). These findings imply that depolarization of cholinergic nerve terminals by cholinomimetics is ineffective in causing the release of ACh and that fundamental differences 
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MATERIALS AND METHODS
Hemidiaphragms from young male Sprague-Dawley rats (100-130 g) were removed under ether anesthesia and mounted in a 5-ml chamber. Bath temperature was kept at 33°C by heating the perfusion fluid, gassed with 95% 02-5% C02, before entry into the chamber. A constant flow rate of 2 ml/-min was maintained using a Holter roller pump. The control solution contained: (mM) NaCl 120; KCl 5; CaCl2 2; M&C12 1; NaH2PO4 1; NaHCO3 24; glucose 17. "K+ Ringer" was made by raising KCl to 13, CaCl2 to 3, and lowering NaCl to 110 mM. The effect of elevating the concentration of K+ was an increase in basal mepp frequency (7) , presumably due to nerve terminal depolarization (8) . Because the frequency increase consisted of both fast and slow* components (9) , diaphragms were equilibrated for at least 1 hr to ensure steadystate conditions. In the majority of cases, 500 nM tetrodotoxin was added to solutions to reduce muscle twitching and the possibility of antidromic backfiring along the motor nerve. Tetrodotoxin has been reported to have no effect on spontaneous transmitter release (10) , and no differences in results were seen in the presence or absence of tetrodotoxin.
Glass microelectrodes filled with 3 M KCl (15) (16) (17) (18) (19) (20) were connected to a high impedance input preamplifier. To prevent baseline drift, the output was ac-coupled to the oscilloscope. A variable low-pass filter was used to improve the mepp signal-to-noise ratio. Record traces were photographed on moving 35-mm film. The output from the preamplifier was also dc-coupled to a chart recorder to monitor resting membrane potentials and postjunctional depolarizations by applied drugs. Mepp frequency was used to assess transmitter release and drug effects were indicated by alterations in mepp frequency. Single junctions were observed for a control period of 10 min a period of drug exposure, and in most cases, a period of wash-out of drug-containing solutions. Focal Fig. 3 ). Tetrodotoxin present, 500 nM. (bottom) Simultaneous recording of membrane potential of the partially depolarized endplate (normal = -70 mV) shown in the above figure. Points taken from continuous chart record every 2 min. Note the synchronous response at both muscle endplate and nerve terminal.
(top), the slope of the line gives the rate of increase. A plot of the log of the carbachol concentration against the rate of increase corresponds to the lower end of a typical dose-response curve (Fig. 3) . The threshold dose for the increase in mepp frequency is 2 MM, in agreement with values for endplate depolarization by carbachol (12) . Thus, the results indicate that the increase in mepp frequency is clearly dependent on the concentration of carbachol applied.
Several findings suggest a similarity between the pre-and postjunctional cholinoceptive sites: e.g., the threshold dose for the carbachol-induced frequency increase (Fig. 3) is identical to that for endplate depolarization, and the time course of action (Fig. 2, top, bottom) for the two responses to carbachol is similar. To examine whether blocking agents also act at both pre-and postjunctional sites, preparations were pretreated with d-tubocurarine (dTC) for 30 min and then exposed to a test dose of carbachol (30 MuM) which always gives a sizeable mepp frequency increase (Fig. 3) . Although dTC reduces mepp amplitudes and thus shortens the interval during which mepps can be confidently counted (see Methods (Nishi, ref. 3). A similar lack of effect of ACh on spontaneous transmitter release has been reported for the neuromuscular junction (4) . By contrast, the present results provide unequivocal evidence that transmitter release at the neuromuscular junction can be evoked by cholinomimetic compounds. Katz and Miledi (11) have mentioned that ACh occasionally increases the frequency of mepps and relate the variability of the response to ACh to the initial level of the resting potentials of the nerve terminals. If this is so, then the effect of elevated K+ may be not only to increase the sampling rate of mepps, but also to increase the efficacy of carbachol in enhancing mepp frequency by lowering the nerve terminal resting potential.
The possibility does exist, however, that the increase in mepp frequency produced by carbachol can be explained by K+ released from the carbachol-depolarized endplate (15) . Direct evidence against this possibility can be provided if, for example, the prejunctional response to carbachol is more sensitive to dTC than that of the endplate (16 withstanding, there are strong arguments against the involvement of K+ released from muscle in the prejunctional effects of cholinomimetics (17) . Whereas close intra-arterial injection of antiacetylcholinesterase agents causes antidromic discharges in the motor nerve, injection of K+ does not. Furthermore, at sympathetic ganglia, intense tetanic stimulation of postganglionic cells, which would be expected to release K+, does not cause presynaptic depolarization (Nishi, ref. 3) . Finally, it would appear highly unlikely that such depolarizations of nerve endings by cholinomimetics would occur by a mechanism different from that at other nerves, e.g., vagal Cfibers, where a role for K + release from other sites is untenable.
Since mepp frequency is a function of prejunctional polarization (7, 8) , the increase in mepp frequency by carbachol is consistent with nerve terminal depolarization. The reported decrease by cholinomimetic drugs in transmitter release evoked by nerve stimulation (4, 5) may similarly be explained by depolarization of the nerve terminal, which would reduce the size of the incoming action potential (18) . The effects of nerve terminal depolarization on transmitter release are not clear, however, for depolarization by K+ increases both mepp frequency and evoked quantal release (19) . These data indicate that the effects on transmitter release of nerve terminal depolarization by cholinomimetic compounds are different from those produced by K+. It may be that low levels of depolarization increase calcium conductance (9) and facilitate evoked release, whereas higher levels of depolarization cause a depression of release by a reduction in the size of the action potential (18) . Depending on the amount of depolarization, then, either an increase or a decrease in release might be seen. This possibility suggests that cholinomimetics under appropriate conditions might also increase transmitter release. The failure of investigators (4, 5) to observe increases in release may have been due to the use of Mg++, which reduces the coupling between depolarization and transmitter secretion (pp. 122-123, ref. 19 ). With otherwise drug-free preparations, increases in evoked release have been reported for succinylcholine and decamethonium (20) .
An important discrepancy remaining to be considered concerns the radiotracer studies at sympathetic ganglia, in which it was shown that carbachol fails to promote ACh release from transmitter storage sites (6) . The failure to provide direct evidence of drug-induced transmitter release by the radiotracer method may be due to several factors. It should be noted that there is evidence for receptor desensitization (21) at nerve terminals, since application of high doses of cholinomimetics (2-4 mM) results in, a transient depolarization (3, 4) . It is, therefore, conceivable that the high doses of carbachol used in the radiotracer studies with perfused ganglia (6) cause a rapid desensitization and repolarization of the nerve terminals, so that transmitter release occurs for only a brief period. Because of the relatively long sampling time needed for the assay, the increase in ACh release by carbachol may be obscured. With the 100-fold lower doses of carbachol used in the present and other studies (4, 5) , there would be a smaller, but more prolonged, depolarization so that, at the motor nerve terminal at least, the increase in transmitter release would be more persistent.
If the assumption is made that mepps reflect the release of ACh from storage sites, then the increase in mepp frequency caused by carbachol clearly indicates the ability of cholinomimetic agents to cause ACh release. Thus, exogenously applied cholinomimetic drugs are capable of promoting transmitter release at both cholinergic and adrenergic (2) junctions. Whether or not endogenous ACh is capable of effecting transmitter release as proposed by Burn and Rand (2) and Koelle (22) is highly problematical and remains to be established.
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